| [1] |
SEHN L H, GASCOYNE R D. Diffuse large B-cell lymphoma:optimizing outcome in the context of clinical and biologic heterogeneity[J]. Blood, 2015, 125(1):22-32.
DOI
URL
|
| [2] |
杨融辉, 廖爱军. 伴浆细胞分化的弥漫大B细胞淋巴瘤一例病例报告并文献复习[J]. 实用药物与临床, 2018, 21(6):680-682.
|
| [3] |
KORKOLOPOULOU P, VASSILAKOPOULOS T, MILIONIS V, et al. Recent advances in aggressive large B-cell lymphomas:a comprehensive review[J]. Adv Anat Pathol, 2016, 23(4):202-243.
DOI
URL
|
| [4] |
HU S, XU-MONETTE Z Y, BALASUBRAMANYAM A, et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature:a report from the International DLBCL Rituximab-CHOP Consortium Program Study[J]. Blood, 2013, 121(14):2715-2724.
DOI
URL
|
| [5] |
TERAS L R, DESANTIS C E, CERHAN J R, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes[J]. CA Cancer J Clin, 2016, 66(6):443-459.
DOI
URL
|
| [6] |
ALIZADEH A A, EISEN M B, DAVIS R E, et al. Distinct types of diffuse large B-cell lymphoma identifified by gene expression profiling[J]. Nature, 2000, 403(6769):503-511.
DOI
URL
|
| [7] |
HANS C P, WEISENBURGER D D, GREINER T C, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J]. Blood, 2004, 103(1):275-282.
DOI
URL
|
| [8] |
BRUDNO J, TADMOR T, PITTALUGA S, et al. Discordant bone marrow involvement in non-Hodgkin lymphoma[J]. Blood, 2016, 127(8):965-970.
DOI
URL
|
| [9] |
仲凯励, 黄小会, 王玉涵, 等. 去泛素化酶MYSM1调控人B细胞向浆细胞的分化[J]. 中国实验血液学杂志, 2019, 27(5):1627-1632.
|
| [10] |
DEVIN J, KASSAMBARA A, BRUYER A, et al. Phenotypic characterization of diffuse large B-cell lymphoma cells and prognostic impact[J]. J CLin Med, 2019, 8(7):1047.
DOI
URL
|
| [11] |
赵佳莉, 罗茜, 张敏. 弥漫大B细胞淋巴瘤组织中LncRNA TP73-AS1的检测水平及临床意义[J]. 西部医学, 2020, 32(10):1517-1520.
|
| [12] |
WIGHT J C, CHONG G, GRIGG A P, et al. Prognostication of diffuse large B-cell lymphoma in the molecular era:moving beyond the IPI[J]. Blood Rev, 2018, 32(5):400-415.
DOI
URL
|
| [13] |
张艳, 唐勇, 姚一芸, 等. 头颈部弥漫大B细胞淋巴瘤患者临床特征及预后模型分析研究[J]. 中国癌症杂志, 2020, 30(6):449-455.
|
| [14] |
PFREUNDSCHUH M, TRÜMPER L, OSTERBORG A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B cell lymphoma:a randomised controlled trial by the MabThera International Trial(MInT) Group[J]. Lancet Oncol, 2006, 7(5):379-391.
DOI
URL
|
| [15] |
郑文帅, 管立勋, 程龙灿, 等. 复发/难治性弥漫大B细胞淋巴瘤患者的临床特征及预后分析[J]. 中国实验血液学杂志, 2020, 28(5):1551-1557.
|
